Cite
HARVARD Citation
Kumar, S. et al. (2021). Preclinical characterization of dostarlimab, a therapeutic anti-PD-1 antibody with potent activity to enhance immune function in in vitro cellular assays and in vivo animal models. MAbs. 13 (1), p. . [Online].